| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
3 |
| issn |
0023-7205 |
| issueIdentifier |
37 |
| pageRange |
2472-3 |
| publicationName |
Lakartidningen |
| startingPage |
2472 |
| bibliographicCitation |
Mooe T. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]. Lakartidningen. 2008 Sep;105(37):2472–3. PMID: 19006861. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66baed6ba56232b32d0f9a9ae6749610 |
| date |
200809 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/19006861 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5468
https://portal.issn.org/resource/ISSN/0023-7205 |
| language |
Swedish |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
[Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer] |
| discusses |
http://id.nlm.nih.gov/mesh/M0008434
http://id.nlm.nih.gov/mesh/M0022871
http://id.nlm.nih.gov/mesh/M0001380
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0017012 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D001281Q000188
http://id.nlm.nih.gov/mesh/D000925Q000627
http://id.nlm.nih.gov/mesh/D010975Q000627
http://id.nlm.nih.gov/mesh/D005343Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D010975Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D019317
http://id.nlm.nih.gov/mesh/D000925Q000009
http://id.nlm.nih.gov/mesh/D018570
http://id.nlm.nih.gov/mesh/D014859Q000627
http://id.nlm.nih.gov/mesh/D014859Q000009
http://id.nlm.nih.gov/mesh/D006470Q000139
http://id.nlm.nih.gov/mesh/D001241Q000627
http://id.nlm.nih.gov/mesh/D001241Q000009
http://id.nlm.nih.gov/mesh/D017410
http://id.nlm.nih.gov/mesh/D020521Q000517
http://id.nlm.nih.gov/mesh/D005343Q000009 |